These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22398065)

  • 21. Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; van Bodegraven AA; Jansen JM; Mahmmod N; Kremer W; Siersema PD; Oldenburg B;
    Clin Gastroenterol Hepatol; 2015 Sep; 13(9):1656-61. PubMed ID: 25956835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features of bowel disease in patients aged <50 years in primary care: a large case-control study.
    Stapley SA; Rubin GP; Alsina D; Shephard EA; Rutter MD; Hamilton WT
    Br J Gen Pract; 2017 May; 67(658):e336-e344. PubMed ID: 28347985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.
    Herrinton LJ; Liu L; Levin TR; Allison JE; Lewis JD; Velayos F
    Gastroenterology; 2012 Aug; 143(2):382-9. PubMed ID: 22609382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer.
    Brackmann S; Aamodt G; Andersen SN; Roald B; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Inflamm Bowel Dis; 2010 Mar; 16(3):474-81. PubMed ID: 19714748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P; Sonnenberg A
    Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of colorectal cancer is related to frequent hospitalization of IBD in an Asian population: results from a nationwide study.
    Peng YC; Lin CL; Hsu WY; Chang CS; Yeh HZ; Liao SC; Kao CH
    QJM; 2015 Jun; 108(6):457-63. PubMed ID: 25362095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    Creemers RH; Rezazadeh Ardabili A; Jonkers DM; Leers MPG; Romberg-Camps MJ; Pierik MJ; van Bodegraven AA
    PLoS One; 2021; 16(10):e0258271. PubMed ID: 34610041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the prevalence of colonic neuroendocrine tumors increased in patients with inflammatory bowel disease?
    Derikx LA; Vierdag WM; Kievit W; Bosch S; Hoentjen F; Nagtegaal ID
    Int J Cancer; 2016 Aug; 139(3):535-42. PubMed ID: 26992110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of early colorectal cancer in inflammatory bowel disease.
    Lutgens MW; Vleggaar FP; Schipper ME; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Oldenburg B; Samsom M
    Gut; 2008 Sep; 57(9):1246-51. PubMed ID: 18337322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival.
    Taylor CC; Millien VO; Hou JK; Massarweh NN
    J Surg Res; 2020 Mar; 247():77-85. PubMed ID: 31767275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
    Cohen-Mekelburg S; Schneider Y; Gold S; Ghosh G; Rosenblatt R; Hajifathalian K; Scherl E; Schnoll-Sussman F; Katz P; Steinlauf A
    Dig Dis Sci; 2019 Aug; 64(8):2273-2279. PubMed ID: 30815820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family history as a risk factor for colorectal cancer in inflammatory bowel disease.
    Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
    Gastroenterology; 2001 May; 120(6):1356-62. PubMed ID: 11313305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data.
    Nieminen U; Jussila A; Nordling S; Mustonen H; Färkkilä MA
    Int J Cancer; 2014 Jan; 134(1):189-96. PubMed ID: 23797639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.
    Adams SV; Ahnen DJ; Baron JA; Campbell PT; Gallinger S; Grady WM; LeMarchand L; Lindor NM; Potter JD; Newcomb PA
    World J Gastroenterol; 2013 Jun; 19(21):3241-8. PubMed ID: 23745025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
    Rudolph G; Gotthardt D; Kloeters-Plachky P; Rost D; Kulaksiz H; Stiehl A
    J Hepatol; 2010 Aug; 53(2):313-7. PubMed ID: 20472317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.